8,102 results on '"Multiple Sclerosis, Relapsing-Remitting"'
Search Results
2. ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients
3. Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis (RED4MS)
4. A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis
5. A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation (SOSTOS)
6. Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis (SPRING)
7. Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis (ILLUMINATE)
8. MultiSCRIPT-Cycle 1: Personalized Medicine in Multiple Sclerosis - Pragmatic Platform Trial Embedded Within the SMSC
9. A Study for Tysabri Participant Preference
10. A Study Investigating the Utilization, Effectiveness and Quality of Life in Clinical Practice in Germany for Participants With Relapsing-remitting Multiple Sclerosis Treated With Ozanimod (Zeposia®) (OzEAN)
11. Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis (DanNORMS)
12. The Synergistic Effects of AIH and FES in Persons With MS
13. Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
14. A Study To Evaluate Safety And Efficacy Of Ocrelizumab In Comparison With Fingolimod In Children And Adolescents With Relapsing-Remitting Multiple Sclerosis (Operetta 2)
15. Effects of a Combined Supplementation of Conjugated Linoleic Acid (CLA) and Probiotics (Vivomixx®) as add-on to a First-line Immunotherapy in Relapsing-remitting Multiple Sclerosis (CLAProMS)
16. Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen
17. A Study to Assess the Effectiveness and Safety of Mayzent in Chinese Patients With Relapsing Forms of Multiple Sclerosis
18. Light Stimulation to Improve Visual Function After Optic Neuritis in Persons With Multiple Sclerosis (ONSTIM)
19. Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple Sclerosis (VISTA)
20. Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS (DELIVER-MS)
21. Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
22. A Study of Efficacy and Safety of M2951 in Participants With Relapsing Multiple Sclerosis
23. MRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis (EMPhASIS) (EMPhASIS)
24. A Study to Assess New Participant's Perspectives Beyond Clinical Efficacy of Monoclonal Antibody-Based Relapsing Remitting Multiple Sclerosis (RRMS) Treatments
25. Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis (ENSURE-2)
26. A Study to Investigate the Radiological Onset of Action After Treatment Initiation With Subcutaneous (SC) Natalizumab in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)
27. RItuximab Versus Ocrelizumab in Relapsing-remitting Multiple Sclerosis. (TRIO)
28. Tysabri Observational Program (TOP)
29. Functional Outcomes From Diets in Multiple Sclerosis (FOOD_for_MS)
30. Dendritic Cells Therapy Combined With Immunomodulatory Treatment in Multiple Sclerosis (TolDecCOMBINEM)
31. Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple Sclerosis (MODIF-MS)
32. A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis
33. Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis
34. the EXPOSITION Study (EXPOSITION)
35. Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sclerosis (CLOCK-MS)
36. RC18 in Patients With Relapsing Remitting Multiple Sclerosis：a Phase II Trial
37. A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis
38. Targeting Subclinical Motor and Cognitive Impairment in Patients With Early Onset Multiple Sclerosis (RELIABLE)
39. IMCY-0141 Safety and Efficacy in Multiple Sclerosis - ISEMIS Study
40. Study on the Effectiveness of EGb 761® vs Placebo Used for Cognitive Impairment in Patients With Multiple Sclerosis
41. Evaluation of the Impact of Lesions of the Motor and Proprioceptive Brain and Pan-medullary Pathways on Their Clinically and Electrophysiologically Assessed Function in Multiple Sclerosis (MS-TRACTS)
42. WEBCAMS: Walking Exercise for Brain and Cognition in Adults With Multiple Sclerosis
43. Safety and Effectiveness of Generic Fingolimod (Sphingomod®, Hikma) in Patients With Relapsing-Remitting Multiple Sclerosis in Egypt
44. An Examination of Cognitive Fatigue Using Functional Neuroimaging
45. Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial (TREAT-MS)
46. Serum Neurofilament Light in Multiple Sclerosis
47. Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis (INsIDER)
48. A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis
49. Exercise Effects in Multiple Sclerosis
50. Examining Effects of Tysabri on Cognitive Fatigue Using fMRI
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.